96 related articles for article (PubMed ID: 26265240)
1. Impact of inhalational exposure to ethanol fuel on the pharmacokinetics of verapamil, ibuprofen and fluoxetine as in vivo probe drugs for CYP3A, CYP2C and CYP2D in rats.
Cardoso JL; Lanchote VL; Pereira MP; Capela JM; de Moraes NV; Lepera JS
Food Chem Toxicol; 2015 Oct; 84():99-105. PubMed ID: 26265240
[TBL] [Abstract][Full Text] [Related]
2. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
[TBL] [Abstract][Full Text] [Related]
3. Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats.
Cardoso JL; Lanchote VL; Pereira MP; Capela JM; Lepera JS
Chirality; 2013 Mar; 25(3):206-10. PubMed ID: 23362155
[TBL] [Abstract][Full Text] [Related]
4. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
Kim HJ; Choi JS
Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites.
Wang YH; Jones DR; Hall SD
Drug Metab Dispos; 2004 Feb; 32(2):259-66. PubMed ID: 14744949
[TBL] [Abstract][Full Text] [Related]
6. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
Ling S; Jamali F
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
8. Influence of N-hexane inhalation on the enantioselective pharmacokinetics and metabolism of verapamil in rats.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
Chirality; 2010 Jan; 22(1):29-34. PubMed ID: 19229957
[TBL] [Abstract][Full Text] [Related]
9. Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats.
Xie SS; Hu N; Jing XY; Liu XD; Xie L; Wang GJ; Liu CH
J Pharm Pharmacol; 2010 Apr; 62(4):440-7. PubMed ID: 20604832
[TBL] [Abstract][Full Text] [Related]
10. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic administration of ritonavir on function of cytochrome P450 3A and P-glycoprotein in rats.
Kageyama M; Namiki H; Fukushima H; Terasaka S; Togawa T; Tanaka A; Ito Y; Shibata N; Takada K
Biol Pharm Bull; 2005 Jan; 28(1):130-7. PubMed ID: 15635177
[TBL] [Abstract][Full Text] [Related]
12. A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.
Wang J; Xia S; Xue W; Wang D; Sai Y; Liu L; Liu X
Eur J Pharm Sci; 2013 Nov; 50(3-4):290-302. PubMed ID: 23916407
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Chung JH; Choi DH; Choi JS
Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
[TBL] [Abstract][Full Text] [Related]
14. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
[TBL] [Abstract][Full Text] [Related]
15. [Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice].
Grishanov AIu; Kaledin VI; Zueva TV; Nekhoroshkova EK; Nikolin VP; Liakhovich VV
Biomed Khim; 2003; 49(1):27-34. PubMed ID: 14569871
[TBL] [Abstract][Full Text] [Related]
16. Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.
Choi DH; Shin WG; Choi JS
Eur J Clin Pharmacol; 2008 May; 64(5):445-9. PubMed ID: 18193210
[TBL] [Abstract][Full Text] [Related]
17. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
19. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
Hu N; Xie S; Liu L; Wang X; Pan X; Chen G; Zhang L; Liu H; Liu X; Liu X; Xie L; Wang G
Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
[TBL] [Abstract][Full Text] [Related]
20. Stress is a critical player in CYP3A, CYP2C, and CYP2D regulation: role of adrenergic receptor signaling pathways.
Daskalopoulos EP; Malliou F; Rentesi G; Marselos M; Lang MA; Konstandi M
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E40-54. PubMed ID: 22510709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]